Lyra Therapeutics (LYRA) Amortizatization of Intangibles (2023 - 2024)
Lyra Therapeutics (LYRA) recorded quarterly Amortizatization of Intangibles of $267000.0 in Q4 2024, down 33.42% on a QoQ basis from $401000.0 in Q3 2024, and down 75.46% YoY from $1.1 million in Q1 2024.
Lyra Therapeutics (LYRA) Amortizatization of Intangibles (2023 - 2024) Analysis & Trends
Lyra Therapeutics (LYRA) has reported Amortizatization of Intangibles for 2 consecutive years, with $267000.0 the latest figure, recorded in Q4 2024.
- Amortizatization of Intangibles for Q4 2024 came in at $267000.0, down 75.46% year-over-year; the trailing twelve-month figure through Dec 2024 was $2.3 million (down 34.9% YoY), and the FY2024 annual result was $2.3 million, down 34.9% from the prior year.
- Amortizatization of Intangibles for Q4 2024 stood at $267000.0, down from $401000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.1 million in Q4 2023, with the low at $267000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lyra Therapeutics | 70,995.28 | 70,995.28 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 267,000.00 |
| Dec 31, 2024 | 267,000.00 |
| Sep 30, 2024 | 401,000.00 |
| Sep 30, 2024 | 401,000.00 |
| Jun 30, 2024 | 675,000.00 |
| Jun 30, 2024 | 675,000.00 |
| Mar 31, 2024 | 933,000.00 |
| Mar 31, 2024 | 933,000.00 |
| Dec 31, 2023 | 1.09 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 626,000.00 |
| Jun 30, 2023 | 626,000.00 |
| Mar 31, 2023 | 726,000.00 |
| Mar 31, 2023 | 726,000.00 |